Serum osteoprotegerin levels in healthy controls and cancer patients.

@article{Lipton2002SerumOL,
  title={Serum osteoprotegerin levels in healthy controls and cancer patients.},
  author={Allan Lipton and Suhail Ali and Kim Leitzel and Vernon M. Chinchilli and Lois Witters and Linda L Engle and Donna L Holloway and Pirow Bekker and Colin Robert Dunstan},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2002},
  volume={8 7},
  pages={2306-10}
}
PURPOSE Osteoprotegerin (OPG) is a novel secreted member of the tumor necrosis factor receptor superfamily. In vitro, OPG blocks osteoclastogenesis in a dose-dependent manner. Serum OPG levels were assayed in cancer patients and healthy control subjects using an ELISA. RESULTS OPG levels in healthy controls were significantly higher in sera (0.17 ng/ml) than in plasma (0.14 ng/ml). OPG levels did not differ by age in either control group. Serum was available from patients with solid tumors (n… CONTINUE READING
64 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Similar Papers

Loading similar papers…